Use este identificador para citar ou linkar para este item:
https://ri.ufs.br/jspui/handle/riufs/23838Registro completo de metadados
| Campo DC | Valor | Idioma |
|---|---|---|
| dc.contributor.author | Martins Filho, Paulo Ricardo Saquete | - |
| dc.contributor.author | Kameo, Simone Yuriko | - |
| dc.contributor.author | Mascarenhas‑Oliveira, Ana Carolina | - |
| dc.contributor.author | Vieira, Nivaldo Farias | - |
| dc.contributor.author | Peixoto, André Luis de Santana | - |
| dc.date.accessioned | 2025-11-12T17:29:53Z | - |
| dc.date.available | 2025-11-12T17:29:53Z | - |
| dc.date.issued | 2013-04 | - |
| dc.identifier.citation | MARTINS FILHO, P. R. S. et al. Panitumumab‑induced acneiform rash in a patient with metastatic colon adenocarcinoma. Indian Journal of Dermatology, Mumbai, v. 58, n. 2, mar./abr. 2013. Disponível em: https://journals.lww.com/ijd/fulltext/2013/58020/panitumumab_induced_acneiform_rash_in_a_patient.62.aspx. Acesso em: 12 nov. 2025. | pt_BR |
| dc.identifier.issn | 1998-3611 | - |
| dc.identifier.uri | https://ri.ufs.br/jspui/handle/riufs/23838 | - |
| dc.language | eng | pt_BR |
| dc.publisher | Medknow Publications | pt_BR |
| dc.relation.ispartof | Indian Journal of Dermatology | pt_BR |
| dc.subject | Panitumumab-induced acneiform rash | eng |
| dc.subject | Chemotherapeutic regimens | eng |
| dc.subject | Metastatic colon adenocarcinoma | eng |
| dc.subject | Dermatology | eng |
| dc.title | Panitumumab‑induced acneiform rash in a patient with metastatic colon adenocarcinoma | pt_BR |
| dc.type | Artigo | pt_BR |
| dc.identifier.license | Creative Commons Atribuição-NãoComercial-CompartilhaIgual 4.0 Internacional (CC BY-NC-SA 4.0) | pt_BR |
| dc.description.resumo | Human epidermal growth factor receptor (HER1/EGFR) is a transmembrane glycoprotein of the tyrosine kinase growth factor family that is dysregulated in many solid tumors and correlated with increased metastasis, reduced survival, and poor prognosis. Panitumumab is a fully human immunoglobulin G2 monoclonal antibody that binds specifically to the EGFR with promising results for the treatment of metastatic colorectal cancer when used as monotherapy or when added to standard chemotherapeutic regimens. Despite the favorable toxicity and safety profiles, several adverse events have been reported, including gastrointestinal disorders, metabolism and nutritional disorders, and mild to moderate dermatologic toxicities. In this correspondence, we describe a case of panitumumab-induced acneiform rash in a patient with metastatic colon adenocarcinoma. | pt_BR |
| dc.description.local | Mumbai | pt_BR |
| Aparece nas coleções: | DESL - Artigos de periódicos | |
Arquivos associados a este item:
| Arquivo | Descrição | Tamanho | Formato | |
|---|---|---|---|---|
| PanitumumabInducedAcneiformRash.pdf | 694,25 kB | Adobe PDF | ![]() Visualizar/Abrir |
Os itens no repositório estão protegidos por copyright, com todos os direitos reservados, salvo quando é indicado o contrário.
